Why is Dr Reddy's Labs falling/rising?

As of 11-Aug, Dr Reddys Laboratories Ltd is currently priced at 1,219.20, reflecting an increase of 4.2 (0.35%). The stock has been gaining for the last three days, with a total return of 1.85% during this period, although it has underperformed its sector by 0.56% today. Despite this recent uptick, the stock has shown negative returns over the past week (-0.51%), month (-2.76%), and year (-13.04%). The company benefits from strong long-term fundamentals, including a low debt-to-equity ratio and a healthy return on equity, which may contribute to investor confidence. However, the stock's performance has lagged behind the broader market, as evidenced by its significant underperformance over the past year compared to the market's return.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has underperformed the Sensex, which has shown a slight positive return over the same periods. The stock's year-to-date decline of 12.18% starkly contrasts with the Sensex's gain of 3.15%, indicating a challenging environment for Dr Reddy's Laboratories Ltd. Despite high institutional holdings at 63.1% suggesting confidence from larger investors, the company's flat results in recent quarters and lower return on capital employed may be contributing to its struggles in the market. Overall, while there are positive indicators for long-term growth, the stock's recent movements reflect a complex interplay of factors leading to its current price dynamics.